Article
Combining the DNA methylation markers of circulating tumor cells with immune infiltrating cells to assess recurrence and prognosis and to suggest a therapeutic strategy in stage III-IV colorectal cancer
28 Jul 2025
Abstract excerpt
Introduction: Circulating tumor DNA (ctDNA) methylation markers show potential for early detection of cancer metastasis. This study aimed to identify ctDNA methylation markers predictive of recurrence and prognosis in colorectal cancer (CRC) patients, and to explore the influence of the tumor immune microenvironment on outcomes. Methods: We analyzed 603 overlapping methylation markers from both plasma and tissue...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
